![Kendra Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kendra Adams
Finanzdirektor/CFO bei
C4 THERAPEUTICS, INC.
Vermögen: 197 406 $ am 31.05.2026
Profil
Kendra R.
Adams is currently Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. since 2026.
Former positions include Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Education includes undergraduate studies at Hamilton College (New York).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
C4 THERAPEUTICS, INC. 0,04 % | 22.04.2026 | 45 173 ( 0,04 % ) | 197 406 $ | 31.05.2026 |
Aktive Positionen von Kendra Adams
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Finanzdirektor/CFO | 18.09.2023 |
Ehemalige bekannte Positionen von Kendra Adams
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Ausbildung von Kendra Adams
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
